XML 83 R59.htm IDEA: XBRL DOCUMENT v3.24.3

Financial Assets and Financial Liabilities (Details)			12 Months Ended
	Feb. 22, 2024 shares	Feb. 28, 2023 £ / shares shares	Jun. 30, 2024 AUD ($) $ / shares shares	Jun. 30, 2024 USD ($)	Jun. 30, 2024 GBP (£)	Jun. 30, 2023 AUD ($) $ / shares	Jun. 30, 2023 GBP (£)	Jun. 30, 2022 AUD ($) $ / shares
Financial Assets and Financial Liabilities [Line Items]
Other income
Total exercise price				$ 965
Expire date			Jul. 31, 2023	Jul. 31, 2023	Jul. 31, 2023
Received shares | shares	471,306
Share price | (per share)		£ 1.85	$ 0.27			$ 0.27		$ 0.37
Expected number of shares to be received | shares		457,577
R&D grant			$ 5,375,461			$ 2,592,145		$ 657,715
Ateria [Member]
Financial Assets and Financial Liabilities [Line Items]
Revenue | £							£ 1,000,000
Medical Technology Enterprise Consortium [Member]
Financial Assets and Financial Liabilities [Line Items]
Other income			28,000
R&D grant			$ 1,901,263
FVPL [Member]
Financial Assets and Financial Liabilities [Line Items]
Share options | shares			735,000
Total exercise price | £					£ 1,470,000
Received shares | shares	471,306

X

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2024-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_OtherRevenue
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The cash inflow from the exercise of options.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2024-01-01
-Paragraph 17
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_ProceedsFromExerciseOfOptions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2024-01-01
-Paragraph 126
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&anchor=para_126&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_ResearchAndDevelopmentExpense
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The aggregate amount of the entity's revenue and other operating income. [Refer: Revenue]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2024-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_RevenueAndOperatingIncome
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Expire date.

+ References

No definition available.

+ Details

Name:	imrn_ExpireDate
Namespace Prefix:	imrn_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of received shares.

+ References

No definition available.

+ Details

Name:	imrn_ReceivedShares
Namespace Prefix:	imrn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represent the number of share option under fair value through profit or loss.

+ References

No definition available.

+ Details

Name:	imrn_ShareOptionUnderFairValueThroughProfitOrLoss
Namespace Prefix:	imrn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number of stock bought back by the entity at the exercise price or redemption price.

+ References

No definition available.

+ Details

Name:	imrn_StockRedeemedOrCalledDuringPeriodShare
Namespace Prefix:	imrn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_BusinessCombinationsAxis=imrn_AteriaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=imrn_MedicalTechnologyEnterpriseConsortiumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=imrn_FVPLMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: